Standard Biotools Inc.
LAB
Revenue
37.21M
▼-8.34M▼-18.30%
3 Months ChangeAssets
708.73M
▼-68.94M▼-8.86%
3 Months ChangeLiabilities
198.47M
▼-1.88M▼-0.9384%
3 Months ChangeFree Cash Flow
-63.26M
▼-53.76M▼-566.21%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0000950170-24-119014
2024-09-05
Form 8-K
ID: 0001104659-24-097368
2024-08-30
Form 8-K
ID: 0001104659-24-095596
2024-08-06
Form 10-Q
ID: 0000950170-24-091888
2024-07-31
Form 8-K
ID: 0001104659-24-084362
2024-07-31
Form 8-K
ID: 0000950170-24-088578
2024-07-01
Form 8-K
ID: 0001104659-24-076823
2024-06-03
Form 8-K
ID: 0001104659-24-067384
2024-05-09
Form 10-Q
ID: 0000950170-24-057213
2024-05-08
Form 8-K
ID: 0000950170-24-055791